DalsnaFinance › Analyst accuracy › Cantor Fitzgerald › ABBV target
ABBV Maintained by Cantor Fitzgerald -- Price Target Raised to $285
Cantor Fitzgerald raised the firm's price target on AbbVie (ABBV) to $285 from $265 and keeps an Overweight rating on the shares.
A fact about what Cantor Fitzgerald published, as reported by GuruFocus, not a recommendation from Dalsna Finance; Cantor Fitzgerald is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.